RSV
Naobios partners with SGS to manufacture RSV challenge agent
March 19, 2026Manufacturing and Production Naobios, RSV, SGS
Contract Development and Manufacturing Organisation (CDMO) Naobios has partnered with SGS, a testing, inspection and certification company, to manufacture a …
EMA to review GSK’s Arexvy for RSV prevention in adults aged 50-59
January 29, 2024Medical Communications Arexvy, EMA, Infections and infestations, RSV
GSK has announced that the European Medicines Agency (EMA) has accepted the company’s regulatory application to expand the use of …
GSK shares new data for RSV vaccine Arexvy
October 25, 2023Research and Development Arexvy, GSK, Immunology, RSV, Vaccine
GSK announced positive results from its phase 3 trial which assessed the immune response and safety of Arexvy, its respiratory …
CDC Advisory Committee recommends Pfizer’s RSV vaccine
September 25, 2023Medical Communications Abrysvo, Immunology, Pfizer, RSV
Pfizer has announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has …
FDA approves Pfizer’s vaccine for the prevention of RSV in children
August 22, 2023Research and Development FDA, Paediatrics, Pfizer, RSV
On Monday, Pfizer announced that the US Food and Drug Administration (FDA) has approved Abrysvo for the prevention of respiratory …
Bavarian Nordic announces RSV vaccine did not meet all primary endpoints in phase 3 trial
July 25, 2023Medical Communications Bavarian Nordic, Infections and infestations, RSV, Vaccine, clinical trial
Bavarian Nordic has announced that its phase 3 clinical trial of MVA-BN, its respiratory syncytial virus (RSV) vaccine candidate for …
FDA approves AstraZeneca’s drug to prevent RSV in babies and young children
July 18, 2023Research and Development AstraZeneca, FDA, Immunology, RSV, Vaccine, paediatrics
The US Food and Drug Administration (FDA) has announced that it has approved Beyfortus (nirsevimab-alip) for the prevention of respiratory …
MHRA authorises GSK’s RSV vaccine for older adults
July 10, 2023Medical Communications Arexvy, GSK, Infections and infestations, MHRA, RSV
GSK has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised its Arexvy respiratory syncytial virus (RSV) …
GSK shares positive data for RSV vaccine
June 21, 2023Research and Development GSK, Immunology, RSV, Vaccine, clinical trial
GSK have announced new positive data from the AReSVi-006 phase 3 trial which assessed the efficacy of a single dose …
GSK’s RSV vaccine approved in EU for older adults
June 7, 2023Medical Communications EU, GSK, Infections and infestations, RSV, Vaccine
GSK has announced that the European Commission (EC) has authorised Arexvy, the company’s respiratory syncytial virus (RSV) vaccine for active …
FDA approves Pfizer’s RSV vaccine for older adults
June 1, 2023Research and Development FDA, Infections and infestations, Pfizer, RSV, Vaccine
Global pharmaceutical company Pfizer has announced that the US Food and Drug Administration (FDA) has approved its respiratory syncytial virus …
FDA committee votes in favour of Pfizer’s RSV vaccine for maternal immunisation
May 19, 2023Research and Development FDA, Immunology, Pfizer, RSV, Vaccine, maternal immunisation
Pfizer has announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) from the US Food and Drug Administration …
FDA approves world’s first RSV vaccine
May 4, 2023Medical Communications FDA, RSV, Vaccine, Virology
The US Food and Drug Administration (FDA) has announced that it has approved the world’s first respiratory syncytial virus (RSV) …
Regeneron abandons respiratory syncytial virus therapy after late-stage failure
August 15, 2017Manufacturing and Production, Research and Development RSV, Regeneron, pharma, pharmaceuticals, respiratory syncytial virus
Regeneron has announced that the failure of suptavumab, its experimental treatment for respiratory syncytial virus (RSV), in late-stage trials, the …
Novavax rides high on crest of RSV vaccine wave
August 12, 2015Research and Development AbbVie, MedImmune, Novavax, RSV, vaccines
The vaccine development company Novavax has announced positive top-line data from a mid-stage clinical trial of its candidate vaccine against …
Latest content
FibroFind appoints Lee Borthwick as CEO
